ACHIEVE (ACHV) CEO Andrew Goldberg Receives RSU, Option & PRSU Awards

What Happened

Andrew D. Goldberg, ACHIEVE Life Sciences' CEO, President and Director, was granted three equity awards on April 18, 2026 that are recorded as derivative acquisitions at $0 per share. The awards cover a total of 17,109,164 underlying shares: 1,800,965; 3,601,929; and 11,706,270 shares (aggregate value reported as $0 in the Form 4 because these are compensation awards, not open-market purchases). These are grants of restricted stock units (RSUs), stock options, and performance-based RSUs (PRSUs) per the filing footnotes.

Key Details

• Transaction date: April 18, 2026; Form 4 filed April 21, 2026.
• Awards (all acquired at $0 per share): 1,800,965; 3,601,929; and 11,706,270 shares (total 17,109,164).
• Footnote highlights:
  • F1: Each RSU represents a contingent right to one share at settlement.
  • F2: Standard RSU vesting: 1/4 vests one year after 4/18/2026, then in substantially equal quarterly installments over the next 12 quarters; eligible for accelerated vesting under his employment agreement.
  • F3: Option vesting: 1/4 vests one year after 4/18/2026, then monthly over 36 months; eligible for accelerated vesting.
  • F4: PRSUs vest only upon achievement of up to eight share-price milestones (2x–9x of a reference price) and certain financial conditions; eligible for accelerated vesting.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• No open‑market purchases or sales; these are compensation grants (transaction code A).
• No indication in the provided data of tax-withholding shares, 10b5-1 plans, or late‑filing flags.

Context

• These are compensation awards, not cash purchases — they signal equity-based pay rather than a direct insider purchase or sale.
• RSUs/PRSUs and options include typical multi-year vesting and performance conditions; PRSUs require substantial stock-price and performance milestones to convert into shares.
• Awards are eligible for accelerated vesting under his employment agreement, which can affect timing of when shares become owned/transferable.

Bottom line: ACHIEVE’s CEO was granted large equity awards on 4/18/2026 totaling 17.1M underlying shares under varying vesting/performance conditions; these are compensation grants (not market buys).